Silodosin
Back to searchMolecule Structure
Scientific Name
Silodosin
Description of the Drug
Silodosin is an alpha-1 adrenergic receptor antagonist used to treat symptoms associated with benign prostatic hyperplasia (BPH).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06207
http://www.drugbank.ca/drugs/DB06207
Brand Name(s)
Rapaflo
Company Owner(s)
Amneal Pharmaceuticals Co Gmbh, Msn Laboratories Private Ltd, Ajanta Pharma Ltd, Alembic Pharmaceuticals Ltd, Sandoz Inc, Macleods Pharmaceuticals Ltd, Upsher Smith Laboratories Llc, Aurobindo Pharma Ltd, Hetero Labs Ltd Unit V, Allergan Sales Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Alpha-1a adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL229 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL136973 | |
| DrugBank | DB06207 | |
| PubChem: Thomson Pharma | 14810706 | 14835413 |
| PubChem | 5312125 | |
| Nikkaji | J786.452C | |
| BindingDB | 50160154 | |
| EPA CompTox Dashboard | DTXSID40167045 | |
| DrugCentral | 4151 | |
| ChemicalBook | CB42129460 | CB31463425 |
| Guide to Pharmacology | 493 | |
| rxnorm | RAPAFLO | SILODOSIN |
| PubChem: Drugs of the Future | 12014894 | |
| ChEBI | 135929 | |
| ZINC | ZINC000003806063 |
